This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
European Union Projects
CZ Vaccines has the support of the CDTI to carry out R&D projects that finance research related to COVID-19, and our company, in collaboration with the CSIC, has carried out a project in the field of human vaccines called : “INDUSTRIAL DEVELOPMENT OF THE MVA-COVID-19(S) VACCINE CANDIDATE, AGAINST SARS-CoV-2”. This project has been co-financed by the European Regional Development Fund (FEDER), a way of making Europe.
The main objective is to develop the GMP industrial production process of the MVA-COVID-19(S) vaccine candidate obtained by the CNB-CSIC Poxvirus and vaccines group against the SARS-CoV-2 coronavirus.
This project has been carried out at the company’s headquarters, in O Porriño, Galicia. Its execution schedule has been between April 2020 and October 2021. The project budget has been €624,759, and we have had the help of the CDTI and the Feder funds.